Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 23, 2016International Journal for Parasitology Drugs and Drug ResistanceOpen Access

Evaluation of Giardia lamblia thioredoxin reductase as drug activating enzyme and as drug target

View Full Paper
Ask AI
Bookmark
Share

Authors

DLDavid LeitschJMJoachim MüllerNMNorbert Müller

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Leitsch et al. (2016) studied this question.

synapsesocial.com/papers/6a9055bf6419f6799027a393https://doi.org/10.1016/j.ijpddr.2016.07.003
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1<i>Entamoeba histolytica</i>: identification of thioredoxin-targeted proteins and analysis of serine acetyltransferase-1 as a prototype example2013 · 32 citations
  2. 2<i>Trichomonas vaginalis</i>: metronidazole and other nitroimidazole drugs are reduced by the flavin enzyme thioredoxin reductase and disrupt the cellular redox system. Implications for nitroimidazole toxicity and resistance2009 · 170 citations
  3. 3Neogenesis and maturation of transient Golgi-like cisternae in a simple eukaryote2009 · 93 citations
  4. 4Nitroreductase (GlNR1) increases susceptibility of Giardia lamblia and Escherichia coli to nitro drugs2011 · 64 citations
  5. 5A Reprofiled Drug, Auranofin, Is Effective against Metronidazole-Resistant Giardia lamblia2013 · 145 citations